BioSpace News Archive

Life Science Tools Market Size to Reach US$ 95.68 BN by 2027

As per Precedence Research, the global life science tools market is poised to grow at a CAGR of 8.5% from 2020 to 2027 and to reach valuation US$ 95.68 billion by 2027.

March 28, 2022
·
5 min read
Pharm Country

Announcing Olympus as a 2022 Edison Award Finalist

Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures, announced it is a 2022 Edison Award Finalist for its iTind™ Procedure, which is nominated within the Science and Medical category for Medical Treatments.

March 28, 2022
·
3 min read
Skincare Devices Market Size, Trends, Growth, Report 2022 to 2030

According to Report, the global skincare devices market size is expected to be worth around USD 33.3 billion by 2030 and registering growth at a CAGR of 10.9% from 2022 to 2030.

March 28, 2022
·
4 min read
Business

Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results

Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing innovative medicines based on cancer cell biology, reported its financial results and business highlights for the fourth quarter and full year ended December 31, 2021.

March 28, 2022
·
10 min read
Pharm Country

Nevakar Injectables Announces the Launch of Ready-to-Use Ephedrine Injection Vials

Nevakar Injectables Inc., a biopharmaceutical company developing multiple sterile injectable products for use in the critical and ambulatory care settings, announced the launch of its ready-to-use Ephedrine Sulfate Injection, a formulation pre-diluted to a 5mg/mL concentration and supplied in a 10mL vial.

March 28, 2022
·
2 min read
Business

Biogen and Ionis Announce Topline Phase 1 Study Results of Investigational Drug in C9orf72 Amyotrophic Lateral Sclerosis

Biogen Inc. (Nasdaq: BIIB) and Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced topline results from the Phase 1 study of BIIB078 (IONIS-C9Rx), an investigational antisense oligonucleotide (ASO) for people with C9orf72-associated amyotrophic lateral sclerosis (ALS).

March 28, 2022
·
9 min read
Endo Begins Shipment of Premixed Ephedrine Sulfate Injection in Ready-to-Use Vials

Endo International plc (NASDAQ: ENDP) announced today that its Par Sterile Products business has begun shipping premixed Ephedrine Sulfate Injection in a ready-to-use 50 mg/10 ml single-use vial.

March 28, 2022
·
6 min read
Business

Access Vascular, Inc. Opens New Facility Outside Boston With Expanded Production Capacity to Meet Growing Demand for Its Biomaterial Devices

Access Vascular, Inc., a company addressing the most common and costly vascular access complications, announced the opening of its new, 40,000 square-foot facility in Billerica, MA.

March 28, 2022
·
2 min read
Business

ORYZON Announces Appointment of Douglas V. Faller, MD, PhD as Global Chief Medical Officer and Continues its Expansion of US Corporate Activities

Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a public clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced today the appointment of Douglas Faller, M.D., Ph.D., to the role of Global Chief Medical Officer.

March 28, 2022
·
8 min read
Biotech Beach

Arcutis Highlights Growth Opportunities at Investor Day in Advance of 2022 Catalysts

Arcutis Biotherapeutics, Inc., a late-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, outlines the company’s growth strategy and continued clinical progress of its broad immuno-dermatology pipeline during Investor Day in Boston.

March 28, 2022
·
7 min read